Influence of intestinal transporter genetic variants on the bioavailability of gabapentin
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gabapentin (Primary)
- Indications Epilepsy; Neuralgia; Neuropathic pain; Postherpetic neuralgia
- Focus Pharmacogenomic; Pharmacokinetics
- 09 Aug 2012 Biomarkers information updated
- 24 Mar 2011 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
- 24 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.